215 related articles for article (PubMed ID: 33069886)
1. Cost-Effectiveness of Biologics for Allergic Diseases.
Wu AC; Fuhlbrigge AL; Robayo MA; Shaker M
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1107-1117.e2. PubMed ID: 33069886
[TBL] [Abstract][Full Text] [Related]
2. Treatments of refractory eosinophilic lung diseases with biologics.
Asano K; Suzuki Y; Tanaka J; Kobayashi K; Kamide Y
Allergol Int; 2023 Jan; 72(1):31-40. PubMed ID: 36333218
[TBL] [Abstract][Full Text] [Related]
3. New opportunities with biologic treatments in pediatric allergic and respiratory diseases.
Tenero L; Piacentini G
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):8-10. PubMed ID: 35080293
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic respiratory disorders and the impact of biologics.
Bernstein JS; Wechsler ME
Curr Opin Pulm Med; 2023 May; 29(3):202-208. PubMed ID: 36866734
[TBL] [Abstract][Full Text] [Related]
5. New biologics for allergic diseases.
Manka LA; Wechsler ME
Expert Rev Clin Immunol; 2018 Apr; 14(4):285-296. PubMed ID: 29611440
[TBL] [Abstract][Full Text] [Related]
6. Severe Asthma and Biologics: Managing Complex Patients.
Matucci A; Micheletto C; Vultaggio A
J Investig Allergol Clin Immunol; 2023 Jun; 33(3):168-178. PubMed ID: 36059229
[TBL] [Abstract][Full Text] [Related]
7. Biologics for Eosinophilic Granulomatosis With Polyangiitis-One Size Does Not Fit All: Comment on the Article by Canzian et al.
Caminati M; Giollo A; Senna G; Lunardi C
Arthritis Rheumatol; 2021 Jul; 73(7):1346-1347. PubMed ID: 33605091
[No Abstract] [Full Text] [Related]
8. Adult-onset eosinophilic airway diseases.
Asano K; Ueki S; Tamari M; Imoto Y; Fujieda S; Taniguchi M
Allergy; 2020 Dec; 75(12):3087-3099. PubMed ID: 33040364
[TBL] [Abstract][Full Text] [Related]
9. Strategies for choosing a biologic for your patient with allergy or asthma.
Saco T; Ugalde IC; Cardet JC; Casale TB
Ann Allergy Asthma Immunol; 2021 Dec; 127(6):627-637. PubMed ID: 34642091
[TBL] [Abstract][Full Text] [Related]
10. Real-world super-response to biologics in severe asthma: A French monocentric retrospective cohort study.
Valéry S; Habib-Maillard S; Roche N
Respir Med Res; 2023 Nov; 84():101055. PubMed ID: 37897876
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic immunomodulation in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Puéchal X
Joint Bone Spine; 2016 Jan; 83(1):7-10. PubMed ID: 26639221
[No Abstract] [Full Text] [Related]
12. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
Raffray L; Guillevin L
Drugs; 2018 Jun; 78(8):809-821. PubMed ID: 29766394
[TBL] [Abstract][Full Text] [Related]
13. Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases.
Del Pozo V; Bobolea I; Rial MJ; Espigol-Frigolé G; Solans Laqué R; Hernández-Rivas JM; Mora E; Crespo-Lessmann A; Izquierdo Alonso JL; Domínguez Sosa MS; Maza-Solano J; Atienza-Mateo B; Bañas-Conejero D; Moure AL; Rúa-Figueroa Í
Front Immunol; 2023; 14():1310211. PubMed ID: 38250075
[TBL] [Abstract][Full Text] [Related]
14. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis.
Nagase H; Ueki S; Fujieda S
Allergol Int; 2020 Apr; 69(2):178-186. PubMed ID: 32139163
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab.
Hočevar A; Kopač P; Rotar Ž; Novljan MP; Škrgat S
J Allergy Clin Immunol Pract; 2020; 8(7):2448-2449. PubMed ID: 32304835
[No Abstract] [Full Text] [Related]
16. Biologics and biomarkers for asthma, urticaria, and nasal polyposis.
Casale TB
J Allergy Clin Immunol; 2017 May; 139(5):1411-1421. PubMed ID: 28477720
[TBL] [Abstract][Full Text] [Related]
17. Focus on the Involvement of the Nose and Paranasal Sinuses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Nasal Cytology Reveals Infiltration of Eosinophils as a Very Common Feature.
Seccia V; Baldini C; Latorre M; Gelardi M; Dallan I; Cristofani-Mencacci L; Sellari-Franceschini S; Bartoli ML; Bacci E; Paggiaro P
Int Arch Allergy Immunol; 2018; 175(1-2):61-69. PubMed ID: 29393242
[TBL] [Abstract][Full Text] [Related]
18. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Pagnoux C; Groh M
Expert Rev Clin Immunol; 2016 Oct; 12(10):1059-67. PubMed ID: 27191665
[TBL] [Abstract][Full Text] [Related]
19. Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis.
Padoan R; Chieco Bianchi F; Marchi MR; Cazzador D; Felicetti M; Emanuelli E; Vianello A; Nicolai P; Doria A; Schiavon F
J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3225-3227.e2. PubMed ID: 32505716
[No Abstract] [Full Text] [Related]
20. Biologics for allergic and immunologic diseases.
Morita H; Matsumoto K; Saito H
J Allergy Clin Immunol; 2022 Oct; 150(4):766-777. PubMed ID: 36058723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
